BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 20926536)

  • 1. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Finkielstain GP; Chen W; Mehta SP; Fujimura FK; Hanna RM; Van Ryzin C; McDonnell NB; Merke DP
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E161-72. PubMed ID: 20926536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
    Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia.
    Marino R; Ramirez P; Galeano J; Perez Garrido N; Rocco C; Ciaccio M; Warman DM; Guercio G; Chaler E; Maceiras M; Bergadá I; Gryngarten M; Balbi V; Pardes E; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):427-35. PubMed ID: 21609351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.
    Baş F; Kayserili H; Darendeliler F; Uyguner O; Günöz H; Yüksel Apak M; Atalar F; Bundak R; Wilson RC; New MI; Wollnik B; Saka N
    J Clin Res Pediatr Endocrinol; 2009; 1(3):116-28. PubMed ID: 21274396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.
    Xu C; Jia W; Cheng X; Ying H; Chen J; Xu J; Guan Q; Zhou X; Zheng D; Li G; Zhao J
    Mol Genet Genomic Med; 2019 Jun; 7(6):e671. PubMed ID: 30968594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia.
    Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP
    Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the most common CYP21A2 point mutations in a cohort of congenital adrenal hyperplasia patients from Egypt.
    Essawi M; Mazen I; Fawaz L; Hassan H; ElBagoury N; Peter M; Gaafar K; Amer M; Nabil W; Hohmann G; Soliman H; Sippell W
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):893-900. PubMed ID: 32614782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance.
    Khattab A; Yuen T; Al-Malki S; Yau M; Kazmi D; Sun L; Harbison M; Haider S; Zaidi M; New MI
    Ann N Y Acad Sci; 2016 Jan; 1364(1):5-10. PubMed ID: 26291314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.
    Krone N; Rose IT; Willis DS; Hodson J; Wild SH; Doherty EJ; Hahner S; Parajes S; Stimson RH; Han TS; Carroll PV; Conway GS; Walker BR; MacDonald F; Ross RJ; Arlt W;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E346-54. PubMed ID: 23337727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP21A2 Gene Pathogenic Variants: A Multicenter Study on Genotype-Phenotype Correlation from a Portuguese Pediatric Cohort.
    Santos-Silva R; Cardoso R; Lopes L; Fonseca M; Espada F; Sampaio L; Brandão C; Antunes A; Bragança G; Coelho R; Bernardo T; Vieira P; Morais R; Leite AL; Ribeiro L; Carvalho B; Grangeia A; Oliveira R; Oliveira MJ; Rey V; Rosmaninho-Salgado J; Marques B; Garcia AM; Meireles A; Carvalho J; Sequeira A; Mirante A; Borges T;
    Horm Res Paediatr; 2019; 91(1):33-45. PubMed ID: 30889569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
    de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
    Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia.
    Balraj P; Lim PG; Sidek H; Wu LL; Khoo AS
    J Endocrinol Invest; 2013 Jun; 36(6):366-74. PubMed ID: 23027774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia.
    Neocleous V; Ioannou YS; Bartsota M; Costi C; Skordis N; Phylactou LA
    Clin Biochem; 2009 Sep; 42(13-14):1363-7. PubMed ID: 19501079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.
    Milacic I; Barac M; Milenkovic T; Ugrin M; Klaassen K; Skakic A; Jesic M; Joksic I; Mitrovic K; Todorovic S; Vujovic S; Pavlovic S; Stojiljkovic M
    J Endocrinol Invest; 2015 Nov; 38(11):1199-210. PubMed ID: 26233337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype-phenotype correlation and identification of nine novel mutations.
    Wang R; Yu Y; Ye J; Han L; Qiu W; Zhang H; Liang L; Gong Z; Wang L; Gu X
    Steroids; 2016 Apr; 108():47-55. PubMed ID: 26804566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Chen W; Xu Z; Nishitani M; Van Ryzin C; McDonnell NB; Merke DP
    Hum Genet; 2012 Dec; 131(12):1889-94. PubMed ID: 22886582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
    Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease.
    Dolzan V; Stopar-Obreza M; Zerjav-Tansek M; Breskvar K; Krzisnik C; Battelino T
    Eur J Endocrinol; 2003 Aug; 149(2):137-44. PubMed ID: 12887291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele-specific PCR and Next-generation sequencing based genetic screening for Congenital Adrenal Hyperplasia in India.
    Ravichandran L; Korula S; Asha HS; Varghese D; Parthiban R ; Johnson J; Ishwarya J; Shetty S; Cherian KE; Jebasingh F; Kapoor N; Pachat D; Mathai S; Simon A; Rajaratnam S; Paul TV; Thomas N; Chapla A
    Eur J Med Genet; 2021 Dec; 64(12):104369. PubMed ID: 34718183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.